Induction of voriconazole metabolism by rifampin in a patient with acute myeloid leukemia: Importance of interdisciplinary communication to prevent treatment errors with complex medications

被引：47
作者：
Geist, Marcus J. P.
Egerer, Gerlinde
Burhenne, Juergen
Riedel, Klaus-Dieter
Mikus, Gerd
机构：
[1] Univ Heidelberg, Dept Internal Med 6, Clin Pharmacol & Pharmacoepidemiol, D-69120 Heidelberg, Germany
[2] Univ Heidelberg, Dept Internal Med 5, D-69120 Heidelberg, Germany
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2007年 / 51卷 / 09期
关键词：
D O I：
10.1128/AAC.00579-07
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：3455 / 3456
页数：2
相关论文
共 4 条
  • [1] *FDA ANT DRUGS ADV, 2001, BRIEF DOC VOR OR INT
  • [2] Safety of voriconazole in a patient with CYP2C9*2/CYP2C9*2 genotype
    Geist, Marcus J. P.
    Egerer, Gerlinde
    Burhenne, Juergen
    Mikus, Gerd
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (09) : 3227 - 3228
  • [3] Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole
    Hyland, R
    Jones, BC
    Smith, DA
    [J]. DRUG METABOLISM AND DISPOSITION, 2003, 31 (05) : 540 - 547
  • [4] Bioanalytical Method Validation—A Revisit with a Decade of Progress
    Vinod P. Shah
    Kamal K. Midha
    John W. A. Findlay
    Howard M. Hill
    James D. Hulse
    Iain J. McGilveray
    Gordon McKay
    Krys J. Miller
    Rabindra N. Patnaik
    Mark L. Powell
    Alfred Tonelli
    C. T. Viswanathan
    Avraham Yacobi
    [J]. Pharmaceutical Research, 2000, 17 (12) : 1551 - 1557
1